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We investigated the natural history of human Calicivirus infection in the community. Clinical information
was obtained from 99 subjects infected with Norwalk-like viruses (NLV) and 40 subjects infected with Sapporo-
like viruses (SLV) in a prospective, community-based cohort study. NLV infection was common in all age
groups, whereas SLV infection was mainly restricted to children aged !5 years. Symptoms lasted for a median
of 5 and 6 days for NLV and SLV infections, respectively. Disease was characterized by diarrhea during the
first 5 days (87% of patients with NLV infection and 95% of patients with SLV infection) and vomiting on
the first day (74% for NLV and 60% for SLV). Vomiting was less common in children aged !1 year (59% for
NLV and 44% for SLV) than it was among children aged 1 year (175% for NLV and 167% for SLV). Overall,
NLV was detected in 26% of patients up to 3 weeks after the onset of illness. This proportion was highest
(38%) for children aged !1 year. SLV shedding subsided after 14 days. These data show that the durations of
disease and viral shedding of caliciviruses are longer than has been described elsewhere. Therefore, the impact
of these infections may have been underestimated.
Viral gastroenteritis is a common illness in humans,
with high morbidity reported worldwide and substan-
tial mortality reported in developing countries. In re-
cent years, caliciviruses have emerged as an important
cause of viral gastroenteritis in people of all age groups
and the main cause of outbreaks of gastroenteritis in
such institutions as nursing homes and hospitals [1–5].
Numerous outbreaks of Calicivirus infection have been
linked to the consumption of food prepared by infected
food-handlers [1].
The human caliciviruses have been divided into 2
genera on the basis of genome organization, mor-
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phology, and genetic and antigenic properties. Norwalk
virus is the prototype strain for the genus “Norwalk-
like viruses” (NLVs). These small, round-structured vi-
ruses are most commonly found in association with
illness in humans [6]. Sapporo virus is the prototype
strain for the genus “Sapporo-like viruses” (SLVs),
which can infect humans as well.
The cloning and characterization of the Norwalk vi-
rus genome has allowed the development of molecular
detection assays that have been applied in molecular
epidemiological studies [4, 7–9] . By now, it has become
apparent that the NLV genus is in fact a very diverse
group of viruses and that multiple variants or genotypes
cocirculate in the community [10]. Similarly, SLVs were
found to consist of a group of related viruses [11].
Some studies involving volunteer subjects and nu-
merous outbreak investigations have been performed
to improve understanding of the course of infection
and disease in healthy adult volunteers or in outbreaks
of gastroenteritis [12–21]. These studies have resulted
in the so-called “Kaplan criteria,” which are considered
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Table 1. Severity score for gastroenteritis in a
study of human Calicivirus infection.
Symptom Score
Fevera 2
Vomiting during 24 hb
Once 1
2–4 times 2
5 times 3
Duration of vomiting, days
1 1
2 2
3 3
Nausea 1
Abdominal pain 1
Abdominal cramps 1
No. of loose or frequent stools during
past 24 h
1–3 1
4–5 2
6 3
Duration of loose or frequent stools, days
1–4 1
5 2
6 3
Blood in stool 2
Mucus in stool 1
Headache 1
Maximum score 21
NOTE. The score is adapted from the clinical severity score
for rotavirus gastroenteritis [26], with treatment and dehydration
omitted.
a Temperature, 137.5C.
b Maximum no. of episodes of vomiting in a 24-h period.
highly indicative for caliciviral gastroenteritis outbreaks: an in-
cubation period of 15–50 h, presence of acute symptoms (in-
cluding vomiting) in more than one-half of cases and/or di-
arrhea, average duration of symptoms of 12–60 h, a high attack
rate, and stool samples that test negative for bacterial pathogens.
However, little is known about the natural course of Cali-
civirus infections in the community. In a recently completed
study from The Netherlands, caliciviruses were identified as
one of the leading causes of illness, both in children and adults
[22, 23]. In this article, we describe the natural history of NLV
and SLV infections in humans.
MATERIALS AND METHODS
Study design. Information on the natural course of Calici-
virus infection was obtained through a community-based co-
hort study [23]. In brief, the study was performed in co-
operation with the general practice network of The Netherlands
Institute of Primary Health Care (NIVEL). This network con-
sists of ∼44 practices that cover 1% of the Dutch population
and that represent the population with regard to age, sex, re-
gional distribution, and degree of urbanization [22]. The study
was a prospective cohort study with a nested case-control de-
sign. An age-stratified random sample was drawn from the
population registered at general practices. Two consecutive co-
horts were observed for 6 months each (4860 subjects total).
Persons who fulfilled the case definition of gastroenteritis dur-
ing follow-up were included in the nested case-control study.
The case definition of gastroenteritis used in the present study
was 3 loose stools in 24 h, vomiting 3 times in 24 h, loose
stool with 2 additional symptoms, or vomiting with 2 additional
symptoms. Additional symptoms included diarrhea, vomiting,
nausea, fever, abdominal pain, abdominal cramps, and blood
or mucus in stool. All cases kept a medical diary during the 4
weeks after the onset of symptoms. Healthy control subjects
were selected for the same period and matched with cases by
age and geographic location. Stool samples were submitted by
cases (on days 1, 8, 15, and 22 after onset of symptoms) and
control subjects (on days 1 and 8). An episode was considered
to be new if it started after a symptom-free period of 2 weeks.
Informed consent was obtained from patients or their par-
ents or guardians. The study was approved by and conformed
to the guidelines for human experimentation of the Medical
Ethical Committee of the Institute for Applied Scientific Re-
search (TNO), Zeist, The Netherlands.
Detection of NLV and SLV. Both NLV and SLV were de-
tected by reverse-transcriptase (RT)–PCR, as described else-
where [4, 11]. In brief, viral RNA was extracted using the guani-
dinium thiocyanate–silica method [24] and assayed in a generic
RT-PCR with primer pairs JV12/JV13 for NLV and JV33/SR80
for SLV. PCR products were analyzed by means of agarose gel
electrophoresis and confirmed by Southern hybridization with
a set of 5′-biotin–labeled probes.
Clinical information. Clinical information was obtained
from medical diaries kept by cases or their caretakers on a daily
basis for 4 weeks, starting on the day of onset of gastroenteritis.
The diary contained questions about symptoms, such as fever
(temperature,37.5C), vomiting, nausea, abdominal pain, ab-
dominal cramps, loose stool (more loose than usual), diarrhea
(more often than usual), blood in stool, mucus in stool, and
headache.
A severity score for gastroenteritis was created on the basis
of these individual symptoms (table 1) [25], adapted from the
clinical severity score for rotavirus gastroenteritis [26] by omit-
ting treatment and dehydration. The severity scores for cases
were compared with those for rotavirus-infected persons from
the same cohort.
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Figure 1. Proportion of patients with gastroenteritis (GE) associated
with Norwalk-like virus (NLV) infection and Sapporo-like virus (SLV) in-
fection, according to patient age.
RESULTS
In the community-based study, 152 (19.7%) of 772 cases with
gastroenteritis had NLV detected in the first or second stool
sample, and 48 cases (6.2%) of SLV infection were observed.
Thirty-five (4.5%) and 11 (1.4%) of 765 control subjects tested
positive for NLV and SLV, respectively. All samples were also
tested for a variety of bacteria, parasites, and other viruses, as
described elsewhere [6, 23]. The positivity rates in cases were
as follows: Salmonella species, in 0.4% of cases; Campylobacter
species, in 1.3%; rotavirus, in 7.3%; adenovirus, in 3.8%; as-
trovirus, in 2%; Giardia lamblia, in 5%; and Cryptosporidium
species, in 2%.
Data from medical diaries on symptoms were complete for
111 cases with NLV infection and 45 cases with SLV infection.
Dual infections were observed in 12 cases infected with NLV
and 5 cases infected with SLV; these data were excluded from
the analysis of clinical symptoms. Information on NLV and
SLV shedding in follow-up stool samples, which were submitted
at days 15 and 22 after the onset of illness, was available for
89 NLV-infected and 36 SLV-infected cases.
Ages affected. NLVs were detected frequently in cases from
all age groups in the community cohort (figure 1). The pro-
portion of gastroenteritis cases associated with NLV was highest
in children (age, 0.5–17 years; proportion, 14%–19%) and in
elderly patients (age, 65 years; proportion, 13%). SLVs were
detected only in younger children with gastroenteritis (with
19% in children aged !6 months [ by x2 test] andP ! .05
5%–9% of children aged 0.5–11 years testing positive) and in
the oldest age group (3% of cases in persons aged 65 years).
No SLV cases occurred in the 12–64-year-old age group.
Clinical symptoms. The clinical manifestations (table 2)
reported by 99 cases with NLV infection were diarrhea (in 87%
of patients) and vomiting (in 74%). These symptoms were
accompanied by abdominal pain in 51% of patients; abdominal
cramps, in 44%; nausea, in 49%; fever, in 32%; and the presence
of mucus in stool, in 19%. No patients reported having bloody
stools. Diarrhea was relatively more prevalent among NLV-
infected children aged !1 year (in 95% of these children) than
it was among NLV-infected children aged 1 year (in 80%).
A greater proportion of children aged 5–11 years (95%) and
112 years (82%) experienced vomiting, compared with 59%
and 75% of children aged !1 and 1–4 years, respectively.
Symptoms found in SLV-infected cases (table 3) included
diarrhea (in 95% of patients) and vomiting (in 60%). These
symptoms were accompanied by abdominal pain in 45% of
patients; abdominal cramps, in 35%; nausea, in 38%; fever, in
43%; and the presence of mucus in stool, in 13%. No patients
reported having bloody stools. In children aged !1 year, the
prevalences of vomiting (44%), abdominal cramps (22%), ab-
dominal pain (11%), and nausea (22%) were lower than the
prevalences among children aged 1–4 years (80%, 53%, 60%,
and 47%, respectively), but these symptoms can be difficult to
asses in infants.
Duration of symptoms. Clinical symptoms associated with
NLV infection lasted a median of 5 days. The median duration
of symptoms was different for different symptoms (table 2).
Diarrhea lasted longest, with a median duration of 4 days (fig-
ure 2A); however, durations of up to 28 days (the end of the
reporting period) were observed. Vomiting (figure 2B), nausea,
and fever primarily occurred on the first day of illness. The
median duration of the overall symptoms decreased with age:
6 days in children aged !1 year, compared with 4 days in
children aged 1–4 years, 5 days in children aged 5–11 years,
and 3 days in patients aged 12 years.
SLV infection was generally associated with clinical symp-
toms that lasted a median of 6 days. Diarrhea was most com-
mon during the first days of infection, with a median duration
of 5 days (table 3). Vomiting, nausea, and fever were primarily
observed during the first 2 days of illness (data not shown).
The median severity score for both NLV- and SLV-infected
patients was 6 (range, 0–12 and 0–15, respectively). This was
lower than the score for rotavirus-infected patients in the pres-
ent study (median severity score, 8 [range, 0–14]; data not
shown). A severity score of 7 occurred in 44% of the NLV-
infected cases; 31% of the NLV-infected cases had a severity
score of 4–6, and 25% of the cases had mild illness (i.e., a
severity score of 3.)
Viral shedding. The duration of viral shedding was de-
termined by RT-PCR of follow-up stool samples obtained on
days 1, 8, 15, and 22 after onset of illness. Virus could be
detected on the first day of sampling in the stool samples of
78% of all NLV-infected cases and 89% of SLV-infected cases.
Shedding of NLV up to 22 days after the onset of illness was
observed in 26% of the cases (figure 3). In 10% of cases, NLV
could be detected from day 8 up to day 22 (14 days), but not
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Table 2. Symptoms of and symptom durations for Norwalk-like virus infection, according to age
group, for patients with gastroenteritis in a community cohort in The Netherlands.
Patient age, variable
Symptom
Diarrhea Vomiting Fever Nauseaa
Abdominal
paina
Abdominal
crampa
!1 year (n p 37)
Percentage of patients 95 59 24 30 11 41
Duration, days
Median 6 2 1 2 1 2
QR 6 2 1 1 0 2
Range 28 7 9 6 2 6
1–4 years (n p 32)
Percentage of patients 84 75 40 53 63 35
Duration, days
Median 3 1 1 1 1 1
QR 5 0 0 1 2 1
Range 27 5 6 4 11 3
5–11 years (n p 19)
Percentage of patients 74 95 48 76 90 52
Duration, days
Median 1 1 1 1 4 2
QR 3 0 0 1 7 2
Range 7 3 2 5 18 9
12 years (n p 11)
Percentage of patients 91 82 45 55 91 82
Duration, days
Median 2 1 1 2 2 2
QR 2 0 1 2 2 2
Range 21 3 2 6 10 10
All (n p 99)
Percentage of patients 87 74 32 49 51 44
Duration, days
Median 4 1 1 1 2 2
QR 6 1 1 1 4 2
Range 28 7 9 6 18 10
NOTE. QR, quartile range.
a Difficult to determine in children aged !5 years.
on day 1. In the remaining cases (12%), virus was detected
only in the samples obtained on days 8 and/or 15. The per-
centage of cases that continued to shed NLV at day 15 and/or
day 22 was highest in newborns aged !1 year (47% and 38%,
respectively; figure 3). Duration of shedding decreased in all
age groups. Long-term NLV shedding was not associated with
increased severity of disease or prolonged duration of clinical
symptoms (data not shown).
The duration of SLV shedding was shorter than the duration
of NLV shedding. In 89% of the cases, virus could be detected
on day 1, decreasing to 14% by day 15. After 22 days, no SLV
shedding was observed (figure 4). Duration of viral shed-
ding was not associated with prolonged duration of clinical
symptoms.
DISCUSSION
In the present study, we investigated the natural history of
human Calicivirus infections in the community. We showed
that NLV infection was commonly associated with gastroen-
teritis in all age groups in the community, as has been suggested
elsewhere [6, 8, 20, 27, 28], whereas SLV infection was mainly
restricted to children aged !5 years. Symptoms due to NLV
and SLV infections were observed for a median of 5 and 6 days,
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/article-abstract/35/3/246/408476 by Erasm
us U
niversity R
otterdam
 user on 03 June 2019
250 • CID 2002:35 (1 August) • Rockx et al.
Table 3. Symptoms of and symptom durations for Sapporo-like virus infection, according to age group,
for patients with gastroenteritis in a community cohort in The Netherlands.
Patient age, variable
Symptom
Diarrhea Vomiting Fever Nauseaa
Abdominal
paina
Abdominal
crampa
!1 year (n p 18)
Percentage of patients 94 44 50 22 11 22
Duration, days
Median 5 2 2 4 1 2
QR 6 5 3 1 1 1
Range 21 7 7 4 2 3
1–4 years (n p 15)
Percentage of patients 93 80 33 47 60 53
Duration, days
Median 6 2 2 2 4 3
QR 3 1 4 1 3 3
Range 18 21 17 3 6 5
5–11 years (n p 6)
Percentage of patients 100 67 50 67 83 33
Duration, days
Median 2 1 2 1 1 2
QR 3 0 1 0 0 1
Range 7 2 3 2 3 3
All (n p 40)
Percentage of patients 95 60 43 38 45 35
Duration, days
Median 5 2 2 2 2 3
QR 6 1 3 2 3 2
Range 21 21 17 4 6 5
NOTE. Only 1 patient was aged 12 years and is therefore not separately presented in table. QR, quartile range.
a Difficult to determine in children aged !5 years.
respectively, which is longer than the durations described else-
where [12, 16, 29]. The prevalence of vomiting in both NLV-
infected and SLV-infected cases was lower in children aged !1
year than it was in children aged 1 year. NLV could be de-
tected in stool samples up to 3 weeks after the onset of illness
in more than one-quarter of the cases. SLV shedding generally
subsided after 14 days.
Several studies of volunteer subjects and epidemiological
studies have been performed to get an insight into the course
of disease associated with NLV infection [12, 14–18, 30]. These
studies have focused either on healthy adults or on at-risk
communities involved in outbreaks of acute nonbacterial gas-
troenteritis, and they have shown that manifestations of disease
lasted for 24–72 h after an incubation period of 12–48 h. Symp-
toms associated with NLV infection included diarrhea, vom-
iting, abdominal cramps, and nausea. We confirm that NLV
and SLV infections are usually mild, and the clinical severity
score for these infections was lower than that for rotavirus
infection [20]. The clinical manifestations associated with NLV
infections appear to be similar in both naturally occurring and
experimentally induced disease [12]. However, in contrast to
studies reported elsewhere [16, 13, 31], our data suggest that
there is a higher prevalence of diarrhea among young children
(age, !5 years), whereas a greater proportion of children aged
5 years experienced vomiting, abdominal cramps, and ab-
dominal pain. A surprising finding in the present study was
the relatively long duration of symptoms (median for NLV
infection, 5 days), whereas illness was generally believed to last
12–60 h [15, 16]. Disease was characterized by diarrhea during
the first 5 days, but durations of diarrhea of up to 28 days after
onset were reported. Vomiting, nausea, and fever occurred on
the first day of disease. The large range in the durations of
symptoms might be explained by differences in the clinical
manifestations of the different virus types, because multiple
genotypes cocirculate in the community [10].
With regard to the duration of symptoms, differences be-
tween the findings of our study and of studies reported else-
where may be because our study focused on infection in the
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Figure 2. Proportion of Norwalk-like virus (NLV) cases associated with diarrhea (A) or vomiting (B) in patients aged !1, 1–4, 5–11, and 12 years
Figure 3. Duration of Norwalk-like virus (NLV) shedding in stool, ac-
cording to age group.
community, whereas other studies have mainly focused on
symptoms associated with outbreaks or experimental infections
in adults. Those studies described the clinical manifestations
for 1 virus type and in an age group for which we found a
shorter duration.
SLV is thought to be a common cause of viral gastroenteritis
in infants and young children [20, 32]. However, little is known
about the clinical manifestations of SLV apart from the findings
of studies of gastroenteritis outbreaks that occurred in infants’
homes [33, 34]. Symptoms associated with SLV infection in-
cluded diarrhea, vomiting, and fever; these symptoms usually
lasted for a median of 6 days (for any symptoms reported).
The progression of the disease was similar to that of NLV in-
fection. The prevalence of fever was higher among SLV-infected
patients than it was among NLV-infected patients.
Despite the high level of NLV infection in children, a con-
siderable proportion of adults still get infected. Serological stud-
ies have shown that antibodies against NLV are obtained early
in life, reaching a prevalence close to 100% at the age of 9–10
years [26, 35–37], and the antibodies remain present through-
out the person’s life [35, 36, 38]. These prevalent antibodies
do not appear to correlate with protective immunity in adults,
given that symptomatic NLV infection of adults is quite com-
mon. In studies of experimental infections of healthy humans,
the presence of antibodies was not associated with protection
against infection [19, 21]. However, the duration of symptoms
decreased with age, which suggests that adults have partial pro-
tection or a generally better-developed immune system.
SLV infection was more common among children aged !1
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Figure 4. Duration of Sapporo-like virus (SLV) shedding in stool, ac-
cording to age group.
year than it was among children aged 1 year. Again, a high
prevalence of antibodies against SLV in adults has been de-
scribed elsewhere [32, 39], and SLV infections were rarely de-
tected in people aged 112 years, which suggests the induction
of protective immunity after exposure to the viruses during
childhood. However, the high prevalence of SLV infection in
children aged !6 months would suggest the absence of maternal
antibodies. The apparent absence of protective immunity
against NLV and its presence for SLV may be explained by the
number of virus types. Because SLV comprises only 4 subtypes,
people are more likely to be challenged by a virus type for
which immunity has already developed. For NLV, this will be
less likely because of the diversity of viruses that cocirculate in
the community [10] (authors’ unpublished data) and the reg-
ular emergence of formerly unknown types (authors’ unpub-
lished data).
For both NLV and SLV, it may be important to test multiple
stool samples obtained at 1-week intervals, because we dem-
onstrated that it was possible to test too early: 22% and 11%
of the NLV and SLV cases, respectively, were not initially de-
tected. In total, 28% of the NLV-infected cases were found to
shed virus up to 22 days after the onset of illness. The duration
of NLV shedding may be even longer, but samples were not
available from later in the course of infection. Long-term shed-
ding correlated with age but not with increased severity of
disease or prolonged duration of clinical symptoms. However,
this long-term shedding, accompanied by the relatively large
group of asymptomatic infections, illustrates the high trans-
mission potential of these viruses. Most patients will resume
normal activities after resolution of symptoms (median, 5 days),
acting as human reservoirs for secondary spread. This might
explain the relatively high incidence of NLV infection in the
community. In studies reported elsewhere, information on NLV
shedding was collected through experimental infections of vol-
unteers; the experimental infections were limited to infection
with Norwalk virus. In those studies, virus was detected directly
by means of electron microscopic evaluation or by detection
of virus antigen via enzyme immunoassays; virus was detected
up to 20 days after infection in 10% of cases [40]. In the subjects
in our study, the higher incidence of viral shedding found at
day 22 may be attributed to the fact that molecular detection
of virus is more sensitive or that viral shedding may differ for
different virus types. This issue will be addressed in a follow-
up study that uses quantitative PCR.
In conclusion, the present study describes the natural history
of human Calicivirus infection in the community and may help
determine the burden of illness due to human Calicivirus in-
fections. Our findings suggest that the burden of illness may
be underestimated when findings are based on historic data on
the duration of illness.
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